JAK2 and myeloproliferative neoplasm: Drivers mutations as JAK2-V617F, CALR, and MPL occur in the hematopoietic stem cells, causing an MPN phenotype or, in presence of another somatic mutations, to a malignant clonal evolution and progression (Figure 1).